American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Public ClinicalTrials.gov record NCT02674100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.
Study identification
- NCT ID
- NCT02674100
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2015
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
- Last update posted
- Feb 24, 2025
2016 – 2030
United States locations
- U.S. sites
- 11
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Birmingham | Birmingham | Alabama | 35233 | Recruiting |
| University of California San Diego | San Diego | California | 92093 | Recruiting |
| University of Colorado | Denver | Colorado | 80309 | Recruiting |
| University of South Florida | Tampa | Florida | 33620 | Recruiting |
| Augusta University | Augusta | Georgia | 30912 | Recruiting |
| University of Louisville | Louisville | Kentucky | 40202 | Recruiting |
| Johns Hopkins Hospital | Baltimore | Maryland | 21218 | Recruiting |
| Atlantic Health | Millburn | New Jersey | 07041 | Recruiting |
| Northwell Health Cancer Institute | Lake Success | New York | 11042 | Recruiting |
| Gibbs Cancer Research, Spartanburg Regional Healthcare System | Spartanburg | South Carolina | 29303 | Recruiting |
| Methodist Digestive Institute | Dallas | Texas | 75203 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02674100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2025 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02674100 live on ClinicalTrials.gov.